Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Gene Therapy
  4. Volume 25, Issue 1
  5. Article
Volume 25, Issue 1
  • ISSN: 1566-5232
  • E-ISSN: 1875-5631

Abstract

L-arginine is a semi-essential amino acid that plays a critical role in various physiological processes, such as protein synthesis, wound healing, immune function, and cardiovascular regulation. The use of L-arginine in pregnancy has been an emerging topic in the field of pharmacogenomics. L-arginine, an amino acid, plays a crucial role in the production of nitric oxide, which is necessary for proper placental development and fetal growth. Studies have shown that L-arginine supplementation during pregnancy can have positive effects on fetal growth, maternal blood pressure, and the prevention of preeclampsia. This emerging pharmacogenomic approach involves using genetic information to personalize L-arginine dosages for pregnant women based on their specific genetic makeup. By doing so, it may be possible to optimize the benefits of L-arginine supplementation during pregnancy and improve pregnancy outcomes. This paper emphasizes the potential applications of L-arginine in pregnancy and the use of pharmacogenomic approaches to enhance its effectiveness. Nonetheless, the emerging pharmacogenomic approach to the application of L-arginine offers exciting prospects for the development of novel therapies for a wide range of diseases.

© 2024 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cgt/10.2174/0115665232262213240329034826
2025-02-01
2024-11-22

  • From This Site

    /content/journals/cgt/10.2174/0115665232262213240329034826
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. World Health Organization. (2020). WHO recommendations on antenatal care for a positive pregnancy experience: Summary.2020https://www.who.int/publications/i/item/9789240001776
  2. American College of Obstetricians and GynecologistsPractice bulletin no. 209: Obstetric analgesia and anesthesia.Obstet. Gynecol.20201353e69e84
     [Google Scholar]
  3. American College of Obstetricians and GynecologistsPractice bulletin no. 202: Gestational diabetes mellitus.Obstet. Gynecol.20201352e49e64
     [Google Scholar]
  4. Shapiro-MendozaC.K. TomashekK.M. KotelchuckM. BarfieldW. NanniniA. WeissJ. DeclercqE. Effect of late-preterm birth and maternal medical conditions on newborn morbidity risk.Pediatrics20081212e223e23210.1542/peds.2006‑362918245397
     [Google Scholar]
  5. TitaA.T.N. AndrewsW.W. DiagnosisP.R. Diagnosis and management of clinical chorioamnionitis.Clin. Perinatol.201946231132731010562
     [Google Scholar]
  6. DuleyL. Pre-eclampsia and the hypertensive disorders of pregnancy.Br. Med. Bull.2019129111114711762
     [Google Scholar]
  7. KramerC.K. CampbellS. RetnakaranR. Gestational diabetes and the risk of cardiovascular disease in women: a systematic review and meta-analysis.Diabetologia201962690591410.1007/s00125‑019‑4840‑230843102
     [Google Scholar]
  8. National institute for health and care excellence. (2020). hypertension in pregnancy: Diagnosis and management. clinical guideline.https://www.nice.org.uk/guidance/cg107
  9. MalikA. MoryaR.K. SahaS. SinghP.K. BhadadaS.K. RanaS.V. Oxidative stress and inflammatory markers in type 2 diabetic patients.Eur. J. Clin. Invest.2020506e1323810.1111/eci.1323832298466
     [Google Scholar]
  10. Gestational hypertension and preeclampsiaGestational hypertension and preeclampsia.Obstet. Gynecol.20201356e237e26010.1097/AOG.000000000000389132443079
     [Google Scholar]
  11. SmithG.C.S. PellJ.P. WalshD. DobbieR. Predicting adverse obstetric outcome after adjustment for risk factors.PLoS Med.200112e18.
     [Google Scholar]
  12. LackovicM. NikolicD. JankovicM. RovcaninM. MihajlovicS. Stroke vs. Preeclampsia: Dangerous liaisons of hypertension and pregnancy.Medicina20235910170710.3390/medicina5910170737893425
     [Google Scholar]
  13. AnanthC.V. KeyesK.M. WapnerR.J. Pre-eclampsia rates in the united states, 1980-2010: Age-period-cohort analysis.BMJ2013347f656410.1136/bmj.f656424201165
     [Google Scholar]
  14. Centers for Disease Control and Prevention. (2021). Pregnancy-related deaths.2021https://www.cdc.gov/reproductivehealth/maternal-mortality/index.html
  15. NewnhamJ.P. DickinsonJ.E. HartR.J. PennellC.E. ArreseC.A. KeelanJ.A. Strategies to prevent preterm birth.Front. Immunol.2014558410.3389/fimmu.2014.0058425477878
     [Google Scholar]
  16. KeilmanC. ShanksA.L. Oligohydramnios.Updated 2022 Sep 12StatPearls.InternetTreasure Island, FLStatPearls Publishing2023https://www.ncbi.nlm.nih.gov/books/NBK562326/
     [Google Scholar]
  17. SoniA. GargS. PatelK. PatelZ. Role of l-arginine in oligohydramnios.J. Obstet. Gynaecol. India201666S127928310.1007/s13224‑016‑0853‑727651617
     [Google Scholar]
  18. HussainS.P. TriversG.E. HofsethL.J. HeP. ShaikhI. MechanicL.E. DojaS. JiangW. SubleskiJ. ShortsL. HainesD. LaubachV.E. WiltroutR.H. DjurickovicD. HarrisC.C. Nitric oxide, a mediator of inflammation, suppresses tumorigenesis.Cancer Res.200464196849685310.1158/0008‑5472.CAN‑04‑220115466171
     [Google Scholar]
  19. VrachnisN. KalampokasE. SifakisS. VitoratosN. KalampokasT. BotsisD. IliodromitiZ. Placental growth factor (PlGF): A key to optimizing fetal growth.J. Matern. Fetal Neonatal Med.20132610995100210.3109/14767058.2013.76669423330778
     [Google Scholar]
  20. BörzsönyiB. DemendiC. NagyZ. TóthK. CsanádM. PajorA. RigóJ.Jr JoóJ.G. Gene expression patterns of insulin-like growth factor 1, insulin-like growth factor 2 and insulin-like growth factor binding protein 3 in human placenta from pregnancies with intrauterine growth restriction.J. Perinat. Med.201139670170710.1515/jpm.2011.09021823995
     [Google Scholar]
  21. GrandoneE. MargaglioneM. ColaizzoD. PavoneG. PaladiniD. MartinelliP. Di MinnoG. Lower birth-weight in neonates of mothers carrying factor V G1691A and factor II A(20210) mutations.Haematologica200287217718111836168
     [Google Scholar]
  22. CaliebeJ. BroekmanS. BoogaardM. BoschC.A.J. RuivenkampC.A.L. OostdijkW. KantS.G. BinderG. RankeM.B. WitJ.M. LosekootM. IGF1, IGF1R and SHOX mutation analysis in short children born small for gestational age and short children with normal birth size (idiopathic short stature).Horm. Res. Paediatr.201277425026010.1159/00033834122572840
     [Google Scholar]
  23. 25.Kawashima Y, Higaki K, Fukushima T, Hakuno F, Nagaishi JI, Hanaki K, Nanba E, Takahashi SI, Kanzaki S. Novel missense mutation in the IGF-I receptor L 2 domain results in intrauterine and postnatal growth retardation.Horumon To Rinsho2012772246254
     [Google Scholar]
  24. MorseK. WilliamsA. GardosiJ. Fetal growth screening by fundal height measurement.Best Pract. Res. Clin. Obstet. Gynaecol.200923680981810.1016/j.bpobgyn.2009.09.00419914874
     [Google Scholar]
  25. Martin WL. Fetal Growth Restriction (FGR). Medicolegal Issues Obstetr Gynaecol2018121125
     [Google Scholar]
  26. ChenEY. Characterizing semiconductor upconverter nanostructures using optical spectroscopic techniques.University of Delaware;2018
     [Google Scholar]
  27. MartinA.M. BindraR. CurcioP. CiceroS. NicolaidesK.H. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation.Ultrasound Obstet. Gynecol.200118658358610.1046/j.0960‑7692.2001.00594.x11844193
     [Google Scholar]
  28. AlfirevicZ. NeilsonJ.P. Doppler ultrasonography in high-risk pregnancies: Systematic review with meta-analysis.Am. J. Obstet. Gynecol.199517251379138710.1016/0002‑9378(95)90466‑27755042
     [Google Scholar]
  29. de OnisM. VillarJ. GülmezogluM. Nutritional interventions to prevent intrauterine growth retardation: evidence from randomized controlled trials.Eur. J. Clin. Nutr.199852Suppl. 1S83S939511024
     [Google Scholar]
  30. ImdadA. BhuttaZA. Effect of balanced protein energy supplementation during pregnancy on birth outcomes.BMC Public Health.2011113193316908634
     [Google Scholar]
  31. HofmeyrG.J. LawrieT.A. AtallahÁ.N. TorloniM.R. TorloniM.R. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.Cochrane Libr.2018201810: CD001059.10.1002/14651858.CD001059.pub530277579
     [Google Scholar]
  32. SibaiB.M. Eclampsia.Am. J. Obstet. Gynecol.199016331049105410.1016/0002‑9378(90)91123‑T2403130
     [Google Scholar]
  33. Mayo Clinic. L-arginine: Safety, side effects, and interactions.Available from: https://www.mayoclinic.org/drugs-supplements-l-arginine/art-20364681 (Accessed March 16, 2022).
  34. BögerR.H. The pharmacodynamics of L-arginine.J. Nutr.200713761650S1655S10.1093/jn/137.6.1650S17513442
     [Google Scholar]
  35. WuG. MeiningerC.J. Nitric oxide and vascular insulin resistance.Biofactors2009351212710.1002/biof.319319842
     [Google Scholar]
  36. HsuC.N. TainY.L. Impact of arginine nutrition and metabolism during pregnancy on offspring outcomes.Nutrients2019117145210.3390/nu1107145231252534
     [Google Scholar]
  37. CarvalhoD.S. DinizM.M. HaidarA.A. CavanalM.F. da Silva AlvesE. CarpinelliA.R. GilF.Z. HirataA.E. L-Arginine supplementation improves insulin sensitivity and beta cell function in the offspring of diabetic rats through AKT and PDX-1 activation.Eur. J. Pharmacol.201679178078710.1016/j.ejphar.2016.10.00127717730
     [Google Scholar]
  38. RacasanS. BraamB. van der GiezenD.M. GoldschmedingR. BoerP. KoomansH.A. JolesJ.A. Perinatal L-arginine and antioxidant supplements reduce adult blood pressure in spontaneously hypertensive rats.Hypertension2004441838810.1161/01.HYP.0000133251.40322.2015184350
     [Google Scholar]
  39. WuG. Imhoff-KunschB. GirardA.W. Biological mechanisms for nutritional regulation of maternal health and fetal development.Paediatric and Perinatal EpidemiologyJohn Wiley & Sons, Ltd 20122642610.1111/j.1365‑3016.2012.01291.x
     [Google Scholar]
  40. MorrisS.M. Arginine metabolism revisited.J Nutr.20111461225792586
     [Google Scholar]
  41. ShirasebF. AsbaghiO. BagheriR. WongA. FigueroaA. MirzaeiK. Effect of l-arginine supplementation on blood pressure in adults: A systematic review and dose–response meta-analysis of randomized clinical trials.Adv. Nutr.20221341226124210.1093/advances/nmab15534967840
     [Google Scholar]
  42. DongJ.Y. QinL.Q. ZhangZ. ZhaoY. WangJ. ArigoniF. ZhangW. Effect of oral l-arginine supplementation on blood pressure: A meta-analysis of randomized, double-blind, placebo-controlled trials.Am. Heart J.2011162695996510.1016/j.ahj.2011.09.01222137067
     [Google Scholar]
  43. DavalosM.E. Hernandez-EsquivelL. Garcia-GuerraA. L-arginine supplementation improves insulin sensitivity and beta-cell function in the offspring of gestational diabetic rats.Am. J. Physiol. Endocrinol. Metab.20102994E548E554
     [Google Scholar]
  44. FacchinettiF. BorellaP. SancesG. FioroniL. NappiR.E. GenazzaniA.R. Oral magnesium successfully relieves premenstrual mood changes.Obstet. Gynecol.19917821771812067759
     [Google Scholar]
  45. KumruS. GodekmerdanA. KumruP. Effects of magnesium supplementation during pregnancy on blood pressure, maternal, and neonatal outcomes: a systematic review and meta-analysis.J. Matern. Fetal Neonatal Med.2018314475486
     [Google Scholar]
  46. Viguier-MartinezM.C. LepercqJ. CauzacM. A double-blind randomized trial of a magnesium sulfate/calcium regimen in the prevention of abruptio placentae.Gynecol. Obstet. Invest.20015129094
     [Google Scholar]
  47. DuleyL. MeherS. AbalosE. Management of pre-eclampsia.BMJ2006332753946346810.1136/bmj.332.7539.46316497761
     [Google Scholar]
  48. PecksU. RathW. An update on the use of magnesium sulphate for fetal neuroprotection in premature birth.Curr. Opin. Obstet. Gynecol.20132529498
     [Google Scholar]
  49. NeriI, Monari F, Sgarbi L, Berardi A, Masellis G, Facchinetti F. L-arginine supplementation in women with chronic hypertension: impact on blood pressure and maternal and neonatal complications.The Journal of Maternal-Fetal & Neonatal Medicine20102312145660
     [Google Scholar]
  50. Parra-CorderoM. Sepúlveda-MartínezA. González-MayaL. L-arginine supplementation improves maternal and neonatal outcome in hypertensive pregnant patients with fetal growth restriction.Hypertens. Pregnancy2019382101108
     [Google Scholar]
  51. KumarA. BegumN. PrasadS. L-arginine supplementation ameliorates oxidative stress and placental hypoxia in a rat model of preeclampsia.Physiol. Rep.2019718e14231
     [Google Scholar]
  52. SalgadoR.M. FavaroR.R. FortunatoR.S. L-arginine supplementation improves insulin signaling in offspring from diabetic rats.J. Endocrinol.20132193139148
     [Google Scholar]
  53. Maleki-SaghooniN. Karimi-ZarchiM. MojarradM. The effect of L-arginine supplementation on serum levels of asymmetric dimethylarginine and lipid profile in women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled trial.Gynecol. Endocrinol.2015315381386
     [Google Scholar]
  54. ZhangZ. ZhouX. ShenM. L-arginine regulates antioxidant enzyme activity and alleviates lipid peroxidation in mitochondria of the postmortem porcine muscle.RSC Advances202111526132622
     [Google Scholar]
  55. FröhlichG. HlavaP. L-arginine improves vascular function by overcoming deleterious effects of ADMA, oxidative stress, and inflammation in elderly humans.Aging Cell2019185e12987
     [Google Scholar]
  56. OnyenekwuC.P. OgahD.M. Effect of L-arginine supplementation on systolic blood pressure in patients with essential hypertension.Int J Res Med Sci.20197829842991
     [Google Scholar]
  57. LiH. LiC. LiL. Supplementation with L-arginine reduces oxidative stress and restores endothelial function in rats with renovascular hypertension.Exp. Ther. Med.20161263917392228101174
     [Google Scholar]
  58. MelilloN. MarinoR. La CaraF. MondaV. MessinaG. Protective role of L-arginine supplementation in cardiovascular diseases: from molecular mechanisms to clinical applications.Int. J. Mol. Sci.2021226308333802957
     [Google Scholar]
  59. ZhouY. XuQ. LiY. L-arginine improves the symptoms of stroke-like episodes in MELAS patients.Neurol. Res.20184015762
     [Google Scholar]
  60. PiattiP. MontiL.D. ValsecchiG. MagniF. SetolaE. MarchesiF. Galli-KienleM. PozzaG. AlbertiK.G.M.M. Long-term oral L-arginine administration improves peripheral and hepatic insulin sensitivity in type 2 diabetic patients.Diabetes Care200124587588010.2337/diacare.24.5.87511347747
     [Google Scholar]
  61. BogerRH Bode-BogerSM Effects of l-arginine on glycemic control in diabetes: A meta-analysis of randomized controlled trials.J. Diabetes Investig.2020113581591
     [Google Scholar]
  62. BuijsN. van BusselF.J. HenryR.M. The potential of l-arginine in the prevention and treatment of pre-eclampsia: A systematic review of randomized controlled trials.J. Hum. Hypertens.20152911695700
     [Google Scholar]
  63. XuL. ZhengY. WangB. YuH. ChangX. WeiL. Effect of l-arginine supplementation on blood pressure in patients with hypertension: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.J. Hypertens.2019373435445
     [Google Scholar]
  64. CasaschiA. MaiocchiG. PadernoD. Novel use of l-arginine for the prevention of contrast-induced nephropathy in patients undergoing cardiovascular interventions: A systematic review and meta-analysis.Eur. J. Clin. Pharmacol.2019754431440
     [Google Scholar]
  65. CaiQ. ZhaoX. HuangX. The potential of l-arginine in cancer therapy: A meta-analysis of clinical trials.Cancer Med.201981526131702882
     [Google Scholar]
  66. GiordanoD. MagaroM.S. CocuzzaC. GiordanoM. The role of l-arginine and nitric oxide in pregnancy.Curr. Pharm. Biotechnol.2019201210081015
     [Google Scholar]
  67. RattanapinyopitukK. SrivorakanY. ChaothaweeL. L-arginine supplementation in adult overweight and obese patients: A systematic review and meta-analysis of randomized controlled trials.J. Nutr. Metab.2020
     [Google Scholar]
  68. EliaE.A. IdrissiM. BellabarbaD. L-Arginine and cerebral ischemic diseases: A review.J. Nutr. Metab.20172017
     [Google Scholar]
  69. AgarwalU. DidelijaI.C. YuanY. WangX. ChenX. MorrowJ.D. Effects of oral L-arginine supplementation on lipid profile and oxidative stress in human subjects.J. Clin. Endocrinol. Metab.2017102249950927841944
     [Google Scholar]
  70. CuiH. HuY. GuoX. SongJ. ChengX. L-arginine supplementation in the prevention and treatment of metabolic diseases: a systematic review.J. Diabetes Investig.2019102386396
     [Google Scholar]
  71. StanhewiczAE AlexanderLM KenneyWL Oral L-arginine supplementation improves cutaneous vascular function in heat-stressed older adults.J Appl Physiol.20171233701707
     [Google Scholar]
  72. SchulmanS.P. BeckerL.C. KassD.A. ChampionH.C. TerrinM.L. FormanS. ErnstK.V. KelemenM.D. TownsendS.N. CapriottiA. HareJ.M. GerstenblithG. L-arginine therapy in acute myocardial infarction: The vascular interaction with age in myocardial infarction (VINTAGE MI) randomized clinical trial.JAMA20062951586410.1001/jama.295.1.5816391217
     [Google Scholar]
  73. DasU.N. L-arginine, NO and asymmetrical dimethylarginine in essential hypertension.Med. Sci. Monit.20051111RA295RA304
     [Google Scholar]
  74. LeeB.J. LinJ.S. LinY.C. LinP.T. Effects of L-arginine supplementation on endurance exercise capacity in athletes.J. Strength Cond. Res.201024257558210.1519/JSC.0b013e3181c6a2f820072040
     [Google Scholar]
  75. JamesP.R. Nelson-PiercyC. Management of hypertension before, during, and after pregnancy.Heart200490121499150410.1136/hrt.2004.03544415547046
     [Google Scholar]
  76. PostonL. BrileyA.L. SeedP.T. KellyF.J. ShennanA.H. Vitamins in Pre-eclampsia (VIP) Trial Consortium Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial.Lancet200636795171145115410.1016/S0140‑6736(06)68433‑X16616557
     [Google Scholar]
  77. VillarJ. Abdel-AleemH. MerialdiM. MathaiM. AliM.M. ZavaletaN. PurwarM. HofmeyrJ. thi Nhu NgocN. CampódonicoL. LandoulsiS. CarroliG. LindheimerM. World Health Organization Calcium Supplementation for the Prevention of Preeclampsia Trial Group World health organization randomized trial of calcium supplementation among low calcium intake pregnant women.Am. J. Obstet. Gynecol.2006194363964910.1016/j.ajog.2006.01.06816522392
     [Google Scholar]
  78. American College of Obstetricians and GynecologistsHypertension in pregnancy. ACOG Practice Bulletin No. 222.Obstet. Gynecol.20201356e237e26010.1097/AOG.000000000000389132443079
     [Google Scholar]
  79. National institute for health and care excellence. hypertension in pregnancy: Diagnosis and management. NICE guideline.2019Available from: https://www.nice.org.uk/guidance/ng133 (Accessed March 16, 2022)
  80. National heart, lung, and blood institute. high blood pressure in pregnancy. updated june.2019Available from: https://www.nhlbi.nih.gov/health-topics/high-blood-pressure-in-pregnancy (Accessed March 16, 2022).
  81. American college of obstetricians and gynecologists’ committee on practice bulletins—gynecologyPractice bulletin no. 200: early pregnancy loss.Obstet. Gynecol.20181325e197e20710.1097/AOG.000000000000289930157093
     [Google Scholar]
  82. VerlohrenS. HerraizI. LapaireO. New gestational hypertension and preeclampsia: pathophysiology, clinical evaluation, and management.Endocr. Rev.202243114634460908
     [Google Scholar]
  83. RouseD.J. HirtzD.G. ThomE. VarnerM.W. SpongC.Y. MercerB.M. IamsJ.D. WapnerR.J. SorokinY. AlexanderJ.M. HarperM. ThorpJ.M.Jr RaminS.M. MaloneF.D. CarpenterM. MiodovnikM. MoawadA. O’SullivanM.J. PeacemanA.M. HankinsG.D.V. LangerO. CaritisS.N. RobertsJ.M. Eunice Kennedy Shriver NICHD Maternal-Fetal Medicine Units Network A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy.N. Engl. J. Med.2008359989590510.1056/NEJMoa080118718753646
     [Google Scholar]
  84. American college of obstetricians and gynecologistsPractice bulletin no. 202: Gestational hypertension and preeclampsia.Obstet. Gynecol.20191331e1e2531241598
     [Google Scholar]
  85. SibaiB.M. Treatment of hypertension in pregnant women.N. Engl. J. Med.1996335425726510.1056/NEJM1996072533504078657243
     [Google Scholar]
  86. American College of Obstetricians and GynecologistsACOG Practice Bulletin No. 58: antepartum fetal surveillance.Obstet. Gynecol.2004104120321315229039
     [Google Scholar]
  87. SibaiB.M. BartonJ.R. Expectant management of severe preeclampsia remote from term: Patient selection, treatment, and delivery indications.Am. J. Obstet. Gynecol.20071966514.e1514.e910.1016/j.ajog.2007.02.02117547875
     [Google Scholar]
  88. MolB.W.J. RobertsC.T. ThangaratinamS. MageeL.A. de GrootC.J.M. HofmeyrG.J. Pre-eclampsia.Lancet201638710022999101110.1016/S0140‑6736(15)00070‑726342729
     [Google Scholar]
  89. LeiboviciJ. ItzhakiO. HuszarM. Sinai J. The tumor microenvironment: Part 1.Immunotherapy.2011311136984
     [Google Scholar]
  90. TsiakkasA. DuvdevaniN. WrightA. Aspirin for the prevention of preterm and term preeclampsia: Systematic review and meta-analysis.Am. J. Obstet. Gynecol.20212244335349.e11
     [Google Scholar]
  91. CauwelsA. BuysE.S. ThoonenR. GearyL. DelangheJ. ShivaS. BrouckaertP. Nitrite protects against morbidity and mortality associated with TNF- or LPS-induced shock in a soluble guanylate cyclase–dependent manner.J. Exp. Med.2009206132915292410.1084/jem.2009123619934018
     [Google Scholar]
  92. BuijsseB. LeeD.M. Associations of hormone replacement therapy and oral contraceptives with ratio of placental weight to birthweight.Paediatr. Perinat. Epidemiol.2006205391399
     [Google Scholar]
  93. Al-DaghriN.M. AlkharfyK.M. Modulation of circulating endothelial progenitor cells and endothelial function by exercise training and resveratrol supplementation in healthy overweight/obese subjects.J. Clin. Endocrinol. Metab.2013984E1153E1159
     [Google Scholar]
  94. VisioliF. GalliC. Antiatherogenic components of olive oil.Curr. Atheroscler. Rep.200131646710.1007/s11883‑001‑0012‑011123850
     [Google Scholar]
  95. CangemiR. AngelicoF. LoffredoL. Del BenM. PignatelliP. MartiniA. VioliF. Oxidative stress-mediated arterial dysfunction in patients with metabolic syndrome: Effect of ascorbic acid.Free Radic. Biol. Med.200743585385910.1016/j.freeradbiomed.2007.06.00217664149
     [Google Scholar]
  96. PaulisL. FicoA. RossiF. Renoprotective effects of uric acid: new weapons against an old enemy?Am. J. Hypertens.2018311010751081
     [Google Scholar]
  97. FangY.Z. YangS. WuG. Free radicals, antioxidants, and nutrition.Nutrition2002181087287910.1016/S0899‑9007(02)00916‑412361782
     [Google Scholar]
  98. LeeI.H. AhnJ. Improvement of endothelial function by a fermented red ginseng extract: A double-blind, randomized, placebo-controlled clinical trial.J. Med. Food2015183367374
     [Google Scholar]
  99. Leja-SzpakA. JaworekJ. The role of nitric oxide and metalloproteinases in the pathogenesis of erosive esophagitis in rats.J. Physiol. Pharmacol.2018693369378
     [Google Scholar]
  100. RoohbakhshA. KarimiG. New perspectives on roles of alpha-lipoic acid in the prevention and treatment of cardiovascular diseases.Oxid. Med. Cell. Longev.201920197621940
     [Google Scholar]
  101. DesideriG. Kwik-UribeC. GrassiD. NecozioneS. GhiadoniL. MastroiacovoD. RaffaeleA. FerriL. BocaleR. LechiaraM.C. MariniC. FerriC. Benefits in cognitive function, blood pressure, and insulin resistance through cocoa flavanol consumption in elderly subjects with mild cognitive impairment: The Cocoa, Cognition, and Aging (CoCoA) study.Hypertension201260379480110.1161/HYPERTENSIONAHA.112.19306022892813
     [Google Scholar]
  102. PalomoI. ContrerasA. Evidence of endothelial dysfunction in obstructive sleep apnea syndrome.Sleep Breath.2012162373378
     [Google Scholar]
  103. OskooeiM.A. NabaviS.F. Cardioprotective effects of flavonoids against doxorubicin-induced cardiotoxicity: A review study.Trends Cardiovasc. Med.2019295313319
     [Google Scholar]
  104. LiuL. LiuZ. The beneficial effects of cocoa flavanols on cardiovascular health.Appl. Physiol. Nutr. Metab.2019449939946
     [Google Scholar]
  105. AlirezaeiM. DezfoulianO. Ascorbic acid improves male fertility by reducing oxidative stress.Fertil. Steril.2009914Suppl.15911595
     [Google Scholar]
  106. SenguptaP. The laboratory rat: Relating its age with human’s.Int. J. Prev. Med.20134662463023930179
     [Google Scholar]
  107. BögerR.H. Bode-BögerS.M. ThieleW. CreutzigA. AlexanderK. FrölichJ.C. Restoring vascular nitric oxide formation by l-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial occlusive disease.J. Am. Coll. Cardiol.19983251336134410.1016/S0735‑1097(98)00375‑19809945
     [Google Scholar]
  108. JobgenW.S. FriedS.K. FuW.J. MeiningerC.J. WuG. Regulatory role for the arginine–nitric oxide pathway in metabolism of energy substrates.J. Nutr. Biochem.200617957158810.1016/j.jnutbio.2005.12.00116524713
     [Google Scholar]
  109. WuG. BazerF.W. DavisT.A. KimS.W. LiP. Marc RhoadsJ. Carey SatterfieldM. SmithS.B. SpencerT.E. YinY. Arginine metabolism and nutrition in growth, health and disease.Amino Acids200937115316810.1007/s00726‑008‑0210‑y19030957
     [Google Scholar]
  110. WuG. MeiningerC.J. Analysis of citrulline, arginine, and methylarginines using high- performance liquid chromatography.Methods Enzymol.200235128629318423217
     [Google Scholar]
  111. NaseemK. The role of nitric oxide in cardiovascular diseases.Mol. Aspects Med.2005261-2336510.1016/j.mam.2004.09.00315722114
     [Google Scholar]
  112. LuikingY.C. PoezeM. DejongC.H. RamsayG. DeutzN.E. Sepsis: An arginine deficiency state?Crit. Care Med.200432102135214510.1097/01.CCM.0000142939.81045.A015483426
     [Google Scholar]
  113. StechmillerJ.K. ChildressB. CowanL. Arginine supplementation and wound healing.Nutr. Clin. Pract.2005201526110.1177/01154265050200015216207646
     [Google Scholar]
  114. ZalbaG. JoséG.S. MorenoM.U. FortuñoM.A. FortuñoA. BeaumontF.J. DíezJ. Oxidative stress in arterial hypertension: Role of NAD(P)H oxidase.Hypertension20013861395139910.1161/hy1201.09961111751724
     [Google Scholar]
  115. SzydłowskiM. ZarembaP. Usnarska-ZubkiewiczL. ŁukasikJ. The role of in improving vascular function in patients with cardiovascular disease.Kardiol. Pol.2021797-8844850
     [Google Scholar]
  116. DevarajS. Vega-LópezS. KaulN. SchönlauF. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile.Lipids20084311112
     [Google Scholar]
  117. OchoaJ.B. CamargoA. Nitric oxide and immune response.Nitric oxide in the nervous system.Academic Press2005745758
     [Google Scholar]
  118. JobgenW.S. FriedS.K. FuW.J. MeiningerC.J. WuG. RegulatoryP. Physiological importance of the endogenous synthesis of arginine in rats.J. Nutr.200613611015
     [Google Scholar]
  119. CookeJ.P. AndonN.A. GirerdX.J. HirschA.T. CreagerM.A. Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta.Circulation19918331057106210.1161/01.CIR.83.3.10571999009
     [Google Scholar]
  120. Le GouillE. JimenezM. BinnertC. Pharmacogenetic analysis of the effects of polymorphisms in ADRB1, ADRB2, AGTR1, AGT, and KNG1 on thiazide diuretic and β-blocker response in essential hypertension.Am. J. Hypertens.201225223123910.1038/ajh.2011.198
     [Google Scholar]
  121. McDonoughC.W. McClureL.A. ZuvichR.L. Association between uridine diphosphate glucuronosyltransferase 1A UDP-glucuronosyltransferase 1A (UGT1A) polymorphisms and adverse reactions/toxicity in participants treated with atorvastatin in the lipid-lowering arm of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).J. Clin. Lipidol.20137213614510.1016/j.jacl.2012.10.002
     [Google Scholar]
  122. SansoneR.A. SansoneL.A. Genetics and psychopharmacology.Psychiatry (Edgmont)2010710202521103140
     [Google Scholar]
  123. BögerR.H. Bode-BögerS.M. ThieleW. JunkerW. AlexanderK. FrölichJ.C. Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease.Circulation19979582068207410.1161/01.CIR.95.8.20689133517
     [Google Scholar]
  124. StafylasP.C. SarafidisP.A. LasaridisA.N. Pharmacogenetics in hypertension: A review of the current knowledge and applications.Expert Opin. Drug Metab. Toxicol.20139334335710.1517/17425255.2013.761792
     [Google Scholar]
  125. BaranziniS.E. MudgeJ. van VelkinburghJ.C. KhankhanianP. KhrebtukovaI. MillerN.A. ZhangL. FarmerA.D. BellC.J. KimR.W. MayG.D. WoodwardJ.E. CaillierS.J. McElroyJ.P. GomezR. PandoM.J. ClendenenL.E. GanusovaE.E. SchilkeyF.D. RamarajT. KhanO.A. HuntleyJ.J. LuoS. KwokP. WuT.D. SchrothG.P. OksenbergJ.R. HauserS.L. KingsmoreS.F. Genome, epigenome and RNA sequences of monozygotic twins discordant for multiple sclerosis.Nature201046472931351135610.1038/nature0899020428171
     [Google Scholar]
  126. ChirkovY.Y. HolmesA.S. WilloughbyS.R. StewartS. HorowitzJ.D. Association of plasma asymmetrical dimethylarginine and cardiovascular risk in patients with hypertension.J. Hypertens.200725116316710.1097/HJH.0b013e3280115cc917143188
     [Google Scholar]
  127. LiH. LiX. LiH. Pharmacogenomics of hypertension: A genome-wide, placebo-controlled cross-over study, using four classes of antihypertensive drugs.J. Am. Coll. Cardiol.2016681829110.1016/j.jacc.2016.03.596
     [Google Scholar]
  128. VitielloM. StanzioneR. FerrarioA. Pharmacogenomics in hypertension therapy: Novel insights and perspectives.High Blood Press. Cardiovasc. Prev.201926425926910.1007/s40292‑019‑00322‑6
     [Google Scholar]
  129. TanakaT. YamaguchiJ. ShojiM. Pharmacogenomics-based personalized therapy: going deeper than genotyping.J. Hum. Genet.2020651273410.1038/s10038‑019‑0675‑5
     [Google Scholar]
  130. MioloA FavarettoE GranzottoM Pharmacogenomics of hypertension and cardiovascular disease. Curr Hypertens Rep.179586
     [Google Scholar]
  131. DamaniaR. CocieruA. Impact of enhanced recovery after surgery protocols on postoperative morbidity and mortality in patients undergoing routine hepatectomy: review of the current evidence.Ann. Transl. Med.201751734110.21037/atm.2017.07.0428936435
     [Google Scholar]
/content/journals/cgt/10.2174/0115665232262213240329034826
Loading
Applications of L-Arginine in Pregnancy and Beyond: An Emerging Pharmacogenomic Approach
Curr. Gene Ther. 25, 22 (2025); https://doi.org/10.2174/0115665232262213240329034826
/content/journals/cgt/10.2174/0115665232262213240329034826
/content/journals/cgt/10.2174/0115665232262213240329034826
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): L-arginine; nitric oxide; oligohydramnios; pharmacogenomics; preeclampsia; pregnancy

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test